Frequency of antiepileptic drugs and response change in pediatric patients receiving 2 or more antiepileptic drugs

被引:1
|
作者
Albsoul-Younes, Abla M. [1 ]
Masri, Amira T. [2 ]
Gharaibeh, Lobna F. [1 ]
Murtaja, Amer A. [1 ]
Al-Qudah, Abdelkarim A. [2 ]
机构
[1] Univ Jordan, Sch Med, Dept Biopharmaceut & Clin Pharm, Amman, Jordan
[2] Univ Jordan, Sch Med, Dept Pediat, Amman, Jordan
关键词
EPILEPSY; CHILDHOOD; ETIOLOGY;
D O I
10.17712/nsj.2020.4.20190113
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To investigate the frequency of changes in antiepileptic drugs (AEDs) use, as well as concomitant changes in the degree of seizure control in pediatric patients, who are receiving 2 or more AEDs. Methods: A prospective follow-up study at Jordan University Hospital's pediatric neurology clinics was conducted on epileptic pediatric patients receiving at least 2 AEDs between December 2013 and April 2014. Patients were followed for 12 months. Results: A total of 82 patients were included, with a mean age of 7.2 +/- 4.7 years. The mean number of AEDs received by patients at enrollment was 2.4 +/- 0.6, and 2.5 +/- 0.7 after follow-up. Most patients (63.4%) experienced no change in seizure control, and the majority reported at least one adverse drug reaction. Most patients received lower doses than recommended, both at the beginning and end of the study. During the year, only 3 patients (4%) were eligible for dose tapering, which would then be converted to monotherapy. Follow-up appointments average was 4.2 +/- 2.9 visits/patients in one year. The frequency of medication changes and dose adjustment was very low, about one-third (29.3%) of patients requiring no change in AEDs during any follow-up visits. Conclusion: During the one year follow-up study, most patients on polytherapy maintained their level of response to the AEDs, with minimal changes in their regimen despite frequent follow-up visits. Only a small percent could be converted to AEDs monotherapy.
引用
收藏
页码:269 / 275
页数:7
相关论文
共 50 条
  • [1] Treatment of hypopituitarism in patients receiving antiepileptic drugs
    Paragliola, Rosa Maria
    Prete, Alessandro
    Kaplan, Peter W.
    Corsello, Salvatore Maria
    Salvatori, Roberto
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (02): : 132 - 140
  • [2] Are elderly patients receiving appropriate antiepileptic drugs?
    Pugh, MJV
    Cramer, JA
    Knoefel, JA
    Charbonneau, A
    Berlowitz, D
    VALUE IN HEALTH, 2003, 6 (03) : 188 - 189
  • [3] Antiepileptic drugs in pediatric epilepsy
    Ravat, Sangeeta H.
    Gupta, Rohit
    JOURNAL OF PEDIATRIC NEUROSCIENCES, 2008, 3 (01) : 7 - 15
  • [4] Antiepileptic drugs in pediatric migraine
    Cuvellier, J. -C.
    Riquet, A.
    Vallee, L.
    ARCHIVES DE PEDIATRIE, 2008, 15 (11): : 1693 - 1699
  • [5] ANTIEPILEPTIC DRUGS IN PEDIATRIC PRACTICE
    BOURGEOIS, BFD
    EPILEPSIA, 1995, 36 : S34 - S45
  • [6] VITAMIN-E STATUS IN PEDIATRIC-PATIENTS RECEIVING ANTIEPILEPTIC DRUGS
    KATAOKA, K
    KANAMORI, N
    OISHI, M
    YAMAJI, A
    TAGAWA, T
    MIMAKI, T
    DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1990, 14 (02): : 96 - 101
  • [7] ZINC CONCENTRATIONS IN LEUKOCYTES OF PATIENTS RECEIVING ANTIEPILEPTIC DRUGS
    YUEN, WC
    WHITEOAK, R
    THOMPSON, RPH
    JOURNAL OF CLINICAL PATHOLOGY, 1988, 41 (05) : 553 - 555
  • [8] Hyperammonemia in children receiving antiepileptic drugs
    Jekovec-Vrhovsek, M
    Perkovic, M
    Zupancic, N
    3RD EPNS CONGRESS (EUROPEAN PAEDIATRIC NEUROLOGY SOCIETY), 1999, : 125 - 128
  • [9] Tumor and antiepileptic drugs Response
    Saria, Marlon G.
    Kesari, Santosh
    JOURNAL OF NEUROSURGERY, 2013, 118 (06) : 1182 - 1182
  • [10] Quantifying the response to antiepileptic drugs
    Schiller, Yitzhak
    Najjar, Yussef
    NEUROLOGY, 2008, 70 (01) : 54 - 65